The rules aren't fully effective yet, but they're already prompting some issuers to list on alternative venues over more tightly regulated markets. As senior bankers and lawyers explain here, confusion over risk factors and registration documents, plus the potential liability of getting it wrong, is scaring market participants off
Portfolio managers want more flexibility on the type of information provided pre-pricing under the Securitisation Regulation. Here they tell Practice Insight why the rules are impossible to meet in their current form
Practice Insight surveys heads of execution, senior in-house counsel, research firm heads and buyside brokers who candidly explain how they're managing the shifting IPO environment
Reporting venues think the new regulation's ISO 20022 requirement will enhance competition between trade repositories. Here they explain why, and reveal the issues they’re still lobbying regulators on
Banks are struggling with repapering for both Brexit and Libor reform. Consultants and regulatory specialists share their project planning and liquidity concerns
Now the rules capture less sophisticated firms, many are forced to outsource repapering, calculation and implementation projects. In-house lawyers explain why they do so at their own risk
Custodian banks are under pressure to ensure they are ready for the phase four initial margin March 2019 deadline, but juggling various legal agreements, KYC checks and Brexit isn’t easy
Many feel that the Securitisation Regulation’s intention is to deter bank investors from buying ABS, while Solvency II amendments are unlikely to bring back insurance firms
Three portfolio managers do not think the new EU Money Market Funds regulation has taken the nuances of different member states into account. They see the introduction of the LVNAV as a hindrance to the market as it’s already turned execution into a lengthy process. A price hike for short-dated commercial paper is expected in response
The proposed directive may ultimately bring back pricing differentiation, but it could also cause significant disruption in the market. Here bankers and investor groups outline the points they are lobbying European regulators on, from asset eligibility to liquidity buffers
Phase five firms are concerned the process of producing figures will lead to conflict. Others are keeping implementation projects on ice in the hope that BCBS-Iosco will bend to their lobbying
